Global /India /Healthcare /Drug Manufacturers - General /506365
chevron_leftBack
Starsource Multitrade Ltd. logo

Starsource Multitrade Ltd.

506365
BSE: 506365 Delayed
123.80INR 4.4%
1.31 USD
As of 21 June 2026, Starsource Multitrade Ltd. has a market cap of $1.97M USD, ranking #47295 globally and #4613 in India. It ranks #4189 in the Healthcare sector, and #1324 in the Drug Manufacturers - General industry.
Global Rank
47295
Country Rank
4613
Sector Rank
4189
Industry Rank
1324
Key Stats
Market Cap
$1.97MUSD
185.7M INR
Enterprise Value
$1.97MUSD
185.71M INR
Revenue (TTM)
$40.51KUSD
3.82M INR
EBITDA (TTM)
-$1.27MUSD
-119.73M INR
Net Income (TTM)
-$1.29MUSD
-121.33M INR
PS Ratio
48.6
PB Ratio
12.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ruchit Mehta open_in_new
Founded
1942
Website
thechemopharmalaboratoriesltd.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
4.4% 9.8% 12% -9.2% -4.5% -11%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
506365 (STARSOURCE)
Chemo Pharma Laboratories Ltd
ISIN: INE320M01019
TV:
SA:
YF:
GF:
BA:
MS:
123.80 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Starsource Multitrade Ltd.

Starsource Multitrade Limited does not have significant operations. The company was previously engaged in the production of pharmaceutical and bulk drug products. The company was formerly known as Chemo Pharma Laboratories Limited and changed its name to Starsource Multitrade Limited in October 2025. The company was incorporated in 1942 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
2M%
39.1
DIVISLAB
$18.38B
1.73T INR
934K%
70.0
$15.17B
1.43T INR
771K%
63.0
$11.73B
1.11T INR
596K%
19.6
MANKIND
$9.87B
931.67B INR
502K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
493K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
39M%
38.1
JNJ
$547.28B
28M%
26.4
ABBV
$360.63B
18M%
97.4
$318.3B
256.25B CHF
16M%
19.9
AZN
$284.64B
215.59B GBP
14M%
27.6
MRK
$274.03B
14M%
15.1
chevron_leftBack